Skip to main content
Top
Published in: Diabetologia 1/2015

01-01-2015 | Article

Vascular heterogeneity between native rat pancreatic islets is responsible for differences in survival and revascularisation post transplantation

Authors: Sara Ullsten, Joey Lau, Per-Ola Carlsson

Published in: Diabetologia | Issue 1/2015

Login to get access

Abstract

Aims/hypothesis

Highly blood-perfused islets have been observed to be the most functional islets in the native pancreas. We hypothesised that differences in vascular support of islets in donor pancreases influence their susceptibility to cellular stress and capacity for vascular engraftment after transplantation.

Methods

Highly blood-perfused islets in rats were identified by injection of microspheres into the ascending aorta before islet isolation. Cell death was evaluated after in vitro cytokine or hypoxia exposure, and 2 days post transplantation. One month post transplantation, islet engraftment, including vascular density, blood perfusion and oxygen tension (pO2) in the tissue, was evaluated.

Results

Microsphere-containing islets had a similar frequency of cell death during standard culture conditions but increased cell death after exposure to cytokines and hypoxia in comparison with other islets. Two days after transplantation the percentage of apoptotic or necrotic cells was also higher in grafts of such islets and 1 month post transplantation these grafts were composed of substantially more connective tissue. Grafts of highly blood-perfused islets in the native pancreas regained a higher vascular density, blood perfusion and pO2 in comparison with grafts of other islets.

Conclusions/interpretation

Native islets that are highly blood-perfused regained this feature after transplantation, indicating a superior capacity for revascularisation and post-transplant function. However, the same group of islets was more vulnerable to different kinds of cellular stress, which limited their early survival post transplantation. Preferential death of these most active islets may contribute to the high number of islets needed to provide cure with islet transplantation.
Literature
1.
go back to reference Olsson R, Olerud J, Pettersson U, Carlsson PO (2011) Increased numbers of low-oxygenated pancreatic islets after intraportal islet transplantation. Diabetes 60:2350–2353PubMedCentralPubMedCrossRef Olsson R, Olerud J, Pettersson U, Carlsson PO (2011) Increased numbers of low-oxygenated pancreatic islets after intraportal islet transplantation. Diabetes 60:2350–2353PubMedCentralPubMedCrossRef
2.
go back to reference Bennet W, Sundberg B, Groth CG et al (1999) Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48:1907–1914PubMedCrossRef Bennet W, Sundberg B, Groth CG et al (1999) Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes 48:1907–1914PubMedCrossRef
3.
go back to reference Lau J, Carlsson PO (2009) Low revascularization of human islets when experimentally transplanted into the liver. Transplantation 87:322–325PubMedCrossRef Lau J, Carlsson PO (2009) Low revascularization of human islets when experimentally transplanted into the liver. Transplantation 87:322–325PubMedCrossRef
4.
go back to reference Henriksnas J, Lau J, Zang G, Berggren PO, Kohler M, Carlsson PO (2012) Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization. Diabetes 61:665–673PubMedCentralPubMedCrossRef Henriksnas J, Lau J, Zang G, Berggren PO, Kohler M, Carlsson PO (2012) Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization. Diabetes 61:665–673PubMedCentralPubMedCrossRef
5.
go back to reference Lee Y, Ravazzola M, Park BH, Bashmakov YK, Orci L, Unger RH (2007) Metabolic mechanisms of failure of intraportally transplanted pancreatic beta-cells in rats: role of lipotoxicity and prevention by leptin. Diabetes 56:2295–2301PubMedCrossRef Lee Y, Ravazzola M, Park BH, Bashmakov YK, Orci L, Unger RH (2007) Metabolic mechanisms of failure of intraportally transplanted pancreatic beta-cells in rats: role of lipotoxicity and prevention by leptin. Diabetes 56:2295–2301PubMedCrossRef
6.
go back to reference Westermark P, Eizirik DL, Pipeleers DG, Hellerstrom C, Andersson A (1995) Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38:543–549PubMedCrossRef Westermark P, Eizirik DL, Pipeleers DG, Hellerstrom C, Andersson A (1995) Rapid deposition of amyloid in human islets transplanted into nude mice. Diabetologia 38:543–549PubMedCrossRef
7.
go back to reference Westermark GT, Westermark P, Berne C, Korsgren O, Nordic Network for Clinical Islet T (2008) Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med 359:977–979PubMedCrossRef Westermark GT, Westermark P, Berne C, Korsgren O, Nordic Network for Clinical Islet T (2008) Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med 359:977–979PubMedCrossRef
8.
go back to reference Abreu JR, Roep BO (2013) Immune monitoring of islet and pancreas transplant recipients. Curr Diabetes Rep 13:704–712CrossRef Abreu JR, Roep BO (2013) Immune monitoring of islet and pancreas transplant recipients. Curr Diabetes Rep 13:704–712CrossRef
9.
go back to reference Lau J, Svensson J, Grapensparr L, Johansson A, Carlsson PO (2012) Superior beta cell proliferation, function and gene expression in a subpopulation of rat islets identified by high blood perfusion. Diabetologia 55:1390–1399PubMedCrossRef Lau J, Svensson J, Grapensparr L, Johansson A, Carlsson PO (2012) Superior beta cell proliferation, function and gene expression in a subpopulation of rat islets identified by high blood perfusion. Diabetologia 55:1390–1399PubMedCrossRef
10.
go back to reference Olsson R, Carlsson PO (2011) A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 60:2068–2075PubMedCentralPubMedCrossRef Olsson R, Carlsson PO (2011) A low-oxygenated subpopulation of pancreatic islets constitutes a functional reserve of endocrine cells. Diabetes 60:2068–2075PubMedCentralPubMedCrossRef
11.
go back to reference Schuit FC, In't Veld PA, Pipeleers DG (1988) Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci U S A 85:3865–3869PubMedCentralPubMedCrossRef Schuit FC, In't Veld PA, Pipeleers DG (1988) Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci U S A 85:3865–3869PubMedCentralPubMedCrossRef
12.
go back to reference Ellenbroek JH, Tons HA, de Graaf N et al (2013) Topologically heterogeneous beta cell adaptation in response to high-fat diet in mice. PLoS One 8:e56922PubMedCentralPubMedCrossRef Ellenbroek JH, Tons HA, de Graaf N et al (2013) Topologically heterogeneous beta cell adaptation in response to high-fat diet in mice. PLoS One 8:e56922PubMedCentralPubMedCrossRef
13.
go back to reference Katsuta H, Aguayo-Mazzucato C, Katsuta R et al (2012) Subpopulations of GFP-marked mouse pancreatic beta-cells differ in size, granularity, and insulin secretion. Endocrinology 153:5180–5187PubMedCentralPubMedCrossRef Katsuta H, Aguayo-Mazzucato C, Katsuta R et al (2012) Subpopulations of GFP-marked mouse pancreatic beta-cells differ in size, granularity, and insulin secretion. Endocrinology 153:5180–5187PubMedCentralPubMedCrossRef
14.
go back to reference Van Schravendijk CF, Kiekens R, Pipeleers DG (1992) Pancreatic beta cell heterogeneity in glucose-induced insulin secretion. J Biol Chem 267:21344–21348PubMed Van Schravendijk CF, Kiekens R, Pipeleers DG (1992) Pancreatic beta cell heterogeneity in glucose-induced insulin secretion. J Biol Chem 267:21344–21348PubMed
15.
go back to reference Schraenen A, Lemaire K, de Faudeur G et al (2010) Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia 53:2589–2599PubMedCentralPubMedCrossRef Schraenen A, Lemaire K, de Faudeur G et al (2010) Placental lactogens induce serotonin biosynthesis in a subset of mouse beta cells during pregnancy. Diabetologia 53:2589–2599PubMedCentralPubMedCrossRef
16.
go back to reference Jansson L, Hellerstrom C (1983) Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 25:45–50PubMedCrossRef Jansson L, Hellerstrom C (1983) Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia 25:45–50PubMedCrossRef
17.
go back to reference Iwase M, Tashiro K, Uchizono Y, Goto D, Yoshinari M (2001) Pancreatic islet blood flow in conscious rats during hyperglycemia and hypoglycemia. Am J Physiol Regul Integr Comp Physiol 280:R1601–R1605PubMed Iwase M, Tashiro K, Uchizono Y, Goto D, Yoshinari M (2001) Pancreatic islet blood flow in conscious rats during hyperglycemia and hypoglycemia. Am J Physiol Regul Integr Comp Physiol 280:R1601–R1605PubMed
18.
go back to reference Andersson A (1978) Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia 14:397–404PubMedCrossRef Andersson A (1978) Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia 14:397–404PubMedCrossRef
19.
go back to reference Mattsson G, Carlsson PO, Olausson K, Jansson L (2002) Histological markers for endothelial cells in endogenous and transplanted rodent pancreatic islets. Pancreatology 2:155–162PubMedCrossRef Mattsson G, Carlsson PO, Olausson K, Jansson L (2002) Histological markers for endothelial cells in endogenous and transplanted rodent pancreatic islets. Pancreatology 2:155–162PubMedCrossRef
20.
go back to reference Carlsson PO, Liss P, Andersson A, Jansson L (1998) Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 47:1027–1032PubMedCrossRef Carlsson PO, Liss P, Andersson A, Jansson L (1998) Measurements of oxygen tension in native and transplanted rat pancreatic islets. Diabetes 47:1027–1032PubMedCrossRef
21.
go back to reference Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005–1029PubMedCrossRef Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005–1029PubMedCrossRef
22.
go back to reference Cetkovic-Cvrlje M, Eizirik DL (1994) TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6:399–406PubMedCrossRef Cetkovic-Cvrlje M, Eizirik DL (1994) TNF-alpha and IFN-gamma potentiate the deleterious effects of IL-1 beta on mouse pancreatic islets mainly via generation of nitric oxide. Cytokine 6:399–406PubMedCrossRef
23.
go back to reference Kolb H, Luckemeyer K, Heise T et al (2013) The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). PLoS One 8:e72440PubMedCentralPubMedCrossRef Kolb H, Luckemeyer K, Heise T et al (2013) The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). PLoS One 8:e72440PubMedCentralPubMedCrossRef
24.
go back to reference Ferreira RC, Guo H, Coulson RM et al (2014) A type I interferon transcriptional signature precedes autoimmunity in children genetically at-risk of type 1 diabetes. Diabetes 67:2538–2550CrossRef Ferreira RC, Guo H, Coulson RM et al (2014) A type I interferon transcriptional signature precedes autoimmunity in children genetically at-risk of type 1 diabetes. Diabetes 67:2538–2550CrossRef
25.
go back to reference Montolio M, Tellez N, Soler J, Montanya E (2007) Role of blood glucose in cytokine gene expression in early syngeneic islet transplantation. Cell Transplant 16:517–525PubMedCrossRef Montolio M, Tellez N, Soler J, Montanya E (2007) Role of blood glucose in cytokine gene expression in early syngeneic islet transplantation. Cell Transplant 16:517–525PubMedCrossRef
26.
go back to reference Mastrandrea L, Yu J, Behrens T et al (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 32:1244–1249PubMedCentralPubMedCrossRef Mastrandrea L, Yu J, Behrens T et al (2009) Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study. Diabetes Care 32:1244–1249PubMedCentralPubMedCrossRef
27.
go back to reference Hughes SJ, Davies SE, Powis SH, Press M (2003) Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets. Transplantation 75:1954–1959PubMedCrossRef Hughes SJ, Davies SE, Powis SH, Press M (2003) Hyperoxia improves the survival of intraportally transplanted syngeneic pancreatic islets. Transplantation 75:1954–1959PubMedCrossRef
28.
go back to reference Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E (2002) Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51:66–72PubMedCrossRef Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E (2002) Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51:66–72PubMedCrossRef
29.
go back to reference Emamaullee JA, Shapiro AM (2007) Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant 16:1–8PubMedCrossRef Emamaullee JA, Shapiro AM (2007) Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant 16:1–8PubMedCrossRef
30.
go back to reference Carlsson PO, Palm F, Andersson A, Liss P (2001) Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50:489–495PubMedCrossRef Carlsson PO, Palm F, Andersson A, Liss P (2001) Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site. Diabetes 50:489–495PubMedCrossRef
31.
go back to reference Eich T, Eriksson O, Sundin A et al (2007) Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 84:893–898PubMedCrossRef Eich T, Eriksson O, Sundin A et al (2007) Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model. Transplantation 84:893–898PubMedCrossRef
32.
go back to reference Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRef Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214PubMedCrossRef
33.
go back to reference Boutilier RG (2001) Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol 204:3171–3181PubMed Boutilier RG (2001) Mechanisms of cell survival in hypoxia and hypothermia. J Exp Biol 204:3171–3181PubMed
34.
go back to reference Kamba T, Tam BY, Hashizume H et al (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560–H576PubMedCrossRef Kamba T, Tam BY, Hashizume H et al (2006) VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol 290:H560–H576PubMedCrossRef
35.
go back to reference Brissova M, Shostak A, Shiota M et al (2006) Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55:2974–2985PubMedCrossRef Brissova M, Shostak A, Shiota M et al (2006) Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55:2974–2985PubMedCrossRef
36.
go back to reference Lammert E, Gu G, McLaughlin M et al (2003) Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 13:1070–1074PubMedCrossRef Lammert E, Gu G, McLaughlin M et al (2003) Role of VEGF-A in vascularization of pancreatic islets. Curr Biol 13:1070–1074PubMedCrossRef
37.
go back to reference Zhang N, Richter A, Suriawinata J et al (2004) Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53:963–970PubMedCrossRef Zhang N, Richter A, Suriawinata J et al (2004) Elevated vascular endothelial growth factor production in islets improves islet graft vascularization. Diabetes 53:963–970PubMedCrossRef
38.
go back to reference Mattsson G, Jansson L, Carlsson PO (2002) Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51:1362–1366PubMedCrossRef Mattsson G, Jansson L, Carlsson PO (2002) Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes 51:1362–1366PubMedCrossRef
Metadata
Title
Vascular heterogeneity between native rat pancreatic islets is responsible for differences in survival and revascularisation post transplantation
Authors
Sara Ullsten
Joey Lau
Per-Ola Carlsson
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3385-7

Other articles of this Issue 1/2015

Diabetologia 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.